CASE STUDY
Revitalizing Business Continuity Management for a Global Biotech Manufacturer
Solution: Our consultancy embarked on a detailed program assessment, identifying and addressing critical gaps in the existing BCM framework.
Our efforts included:
-
Developed a formalized methodology for relaunching the company’s risk assessment, business unit, and site recovery planning processes.
-
Streamlined the creation of actionable recovery plans, significantly reducing the time required to prepare for and respond to potential disruptions.
-
Implemented a consistent, repeatable process for BCM program management, enhancing program support and efficiency.
-
Optimized the use of the existing SaaS BCM tool, making it more user-friendly and effective for end-users.
​
Challenges
-
Siloed BCM efforts
-
Disjointed approach to vulnerability identification
-
No repeatable processes
Benefits
-
Efficiency in Recovery Planning: The time needed to build actionable recovery plans for critical sites was significantly reduced, facilitating a more rapid deployment of these plans globally.
-
Program Consistency: Immediate enhancements to BCM program management resulted in a more consistent, repeatable process across the organization.
-
Tool Optimization: Recommendations for improvements to the current SaaS tool usage were implemented, increasing its utility for the end-users.
-
Siloed Program Integration: Conducting an initial assessment illuminated previously unrecognized weak spots due to siloed program efforts, allowing for targeted improvements.
Quote
"Before engaging with Stone Risk, our BCM efforts felt like disparate pieces of a puzzle, scattered across our global operations.
​
Their assessment and strategic roadmap not only helped us see the full picture but provided us with the tools and methodologies to connect the pieces seamlessly. "
BCM Program Leader
Global Biotechnology Company